期刊文献+

抗HIV广谱中和血清表位特异性研究进展 被引量:2

Advance in identification and analysis of epitope specificities of broadly neutralizing anti-HIV-1 sera
原文传递
导出
摘要 HIV疫苗研究的巨大障碍在于目前设计的包含Env蛋白或表位的疫苗在临床前及临床试验中难于诱导产生广谱中和抗体。近来的研究表明一些HIV-1感染者血清中存在的抗体能够中和多种病毒株,而新的表位作图技术对这些广谱中和血清表位特异性的深入分析将对广谱中和抗体靶向的病毒表位提供新的线索。通过广谱中和血清表位特异性研究获得的信息将促进新的广谱中和单克隆抗体的分离和潜在新表位的鉴定,为合理设计新的疫苗免疫原提供关键信息。 One obstacle to the development of an effective HIV-1 vaccine has been the difficulty in inducing broadly neutralizing antibodies with protective functions.However,recent studies show that antibodies in the sera of some HIV-1 infected individuals can neutralize diverse HIV-1 isolates.Detailed analyses of these sera with recently developed sophistical mapping methods can provide new insights into the viral epitopes targeted by broadly reactive NAbs.The new information emerging from these mapping efforts may be conducive to sharpening efforts to isolate new bnmAbs and moreover,may provide crucial information for the rational design of novel vaccine candidates.
出处 《中国热带医学》 CAS 2011年第5期636-639,共4页 China Tropical Medicine
基金 十一五重大传染病防治研究项目(2008ZX10001-010) 传染病预防控制国家重点实验室课题(2008SKLID101)
关键词 HIV-1 中和 表位特异性 疫苗研制 HIV-1 Neutralization Epitope specificity Vaccine development
  • 相关文献

参考文献26

  • 1Li YX,Migueles SA,Welcher B,et al . Broad HIV-1 neutralization mediated by CD4 binding site antibodies[ J ] . Nat Med, 2007,13(9) : 1032-1034. 被引量:1
  • 2Sather DN,Armann J,Ching LK,et al . Factors associated with the development of cross-reactive neutralizing antibodies during HIV-1 infection [J]. J Virol, 2008,83 (2) : 757-769. 被引量:1
  • 3Simek MD,Rida W,Priddy FH,et al . HIV-1 elite neutralizers: individuals with broad and potent neutralizing activity identified using high throughput neutralization assay together with an analytical selection algorithm[J] . J Virol,2009,83(14) :7337-7348. 被引量:1
  • 4Dhillon AK, Donners H,Pantophlet R, et al. Dissecting the neutralizing antibody speciflcities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors[J] . J Virol,2007,81 ( 12 ) : 6548-6562. 被引量:1
  • 5Binlcy JM,Lybarger EA,Crooks ET,et al . Profiting the specificity of neutralizing antibodies in a large panel of HIV-1 plasmas from subtype B and C chronic infections [J] . J Virol,2008,82 (23): 11651-11668. 被引量:1
  • 6Li Y,Svehla K,Louder MK,et al. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals[J] . J Virol,2009,83(2) : 1045-1059. 被引量:1
  • 7Gray ES,Taylor N,Wycuff D,et al . Antibody specificities associated with neutralization breadth in plasma from HIV-1 subtype C infected blood donors[J] . J Virol, 2009, 83(17) :8925-8937. 被引量:1
  • 8Nandi A,Lavine CL,Wang P,et al . Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1[J] . Virology,2010,396(2) :339-348. 被引量:1
  • 9Gray ES,Madiga MC,Moore PL,et al. Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region [J] . J Virol, 2009,83(21 ) : 11265-1274. 被引量:1
  • 10Davis KL,Bibollet-Ruche F,Li H,et al . Human immunodeficiency vires type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma[J] . J Virol,2009,83(3) : 1240-1259. 被引量:1

同被引文献3

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部